MedPath

Hyperbaric Prilocaine 2% for spinal anesthesia 60 or 80 mg: a dosing study in day care patients.

Phase 4
Completed
Conditions
lokaal anesthesie tbv operatieve ingrepen in dagbehandeling
back injection
spinal anesthesia
Registration Number
NL-OMON47932
Lead Sponsor
anesthesiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Patients requiring spinal anesthesia for lower limb surgery in day case
surgery.

Exclusion Criteria

age younger than 18 yrs
pregnancy
allergy for prilocaine or other amide type local anesthetics
hereditary or acquired methaemoglobinaemia
severe heart conduction abnormalities *
severe anaemia *
unstable cardiac failure *
hypovolemic, cardiogenic or other forms of circulatory shock *

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Maximum block height (sensibility and motor) Time of regression to T10, L1 and<br /><br>S2 (sensibility)<br /><br>Time of regression of motor block<br /><br>Time to spontaneous urination or catherization</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>the amount of fluid infused during and after surgery and the amount of fluids<br /><br>taken postoperatively<br /><br>bladder volume pre and postoperatively and at discharge if the patient did not<br /><br>urinate yet<br /><br>time of first urine production. If the patient does not urinate during<br /><br>admission, he/she will be asked to record the time at home<br /><br>bladder catheterization if necessary and volume additional analgesics per and<br /><br>postoperatively use of vasopressors<br /><br>patient satisfaction with the procedure<br /><br>time of discharge, night admission if necessary and reason for night admission<br /><br><br /><br><br /><br><br /><br>****</p><br>
© Copyright 2025. All Rights Reserved by MedPath